←
Nature Cancer2,045 posts
Nature Cancer avatar

Nature Cancer

@NatureCancer

Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.

◷ Joined January 2019▧ 545 Photos and videos
Nature Cancer avatar
Nature Cancer@NatureCancer·Nov 13

Out today! An AI model infers spatial proteomic patterns at the single-cell level from routine H&E slides to predict molecular biomarkers, prognosis and immunotherapy response nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Nov 2

Online today! OSM and TGFβ1 establish distinct stromal niches that sustain hybrid and late EMT states in mouse skin tumors @CedricBlanpain nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Oct 31

News & Views AI for detection of adverse events in the real world by @GuillaumeJaume & Jakob Nikolas Kather @jnkath 👉nature.com/articles/s43018-0…

Read about an AI agent assisting clinicians in assessing immune-related adverse events now in Nature Cancer! @dbittermanmd nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Oct 31

🌟Online now @ednacukierman, Igor Astsaturov & co uncover that CAFs fuel pancreatic tumor growth and immune suppression by transferring membrane lipids to cancer cells through trogocytosis. nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Oct 30

Now Online! A genome-wide screen in E. coli identifies genetic determinants of intratumoral bacterial fitness and targets for therapeutic application. @arpaialab nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Oct 27

💫Now online! de Sauvage and colleagues discuss the latest advances in therapy-driven cancer plasticity processes 🔗nature.com/articles/s43018-0… Check out the rest of the Series on Tumor Heterogeneity and Plasticity here: nature.com/collections/gfbbj… nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Oct 14

Attending #ESMO26? Our Senior Editor, @Vin_Giacco, will be there and looks forward to connecting with the oncology community. Get in touch to discuss your latest research and publishing opportunities at Nature Cancer.

Looking forward to attending the #ESMO26 Annual Meeting in Madrid! I'll be there representing @NatureCancer and meeting the oncology community. Happy to discuss your latest research, publishing opportunities, or ideas for the journal, please reach out. See you in Madrid 🇪🇸

Post attachment
Nature Cancer avatar
Nature Cancer@NatureCancer·Oct 13

🧬New in Nature Cancer: The phase 2 PEGASUS trial explores a ctDNA-guided strategy to de-escalate or escalate adjuvant therapy in patients with high-risk stage II and stage III colon cancer, moving us closer to more personalised treatment decisions. nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Sep 14

🚨New in Nature Cancer Dr Gong and colleagues report findings from the phase 1 study evaluating L-glutamine + gemcitabine/nab-paclitaxel in untreated advanced PDAC. ORR 44%, including 12.5% CR, with median OS of 22 months. #PancreaticCancer @jgong15 nature.com/articles/s43018-0…

Nature Cancer avatar
Nature Cancer@NatureCancer·Aug 26

Now Online! The neuropeptide galanin impairs antitumor immunity in glioblastoma by interacting with its receptor GALR3 on monocytic myeloid-derived suppressor cells, promoting their infiltration and ferroptosis resistance. nature.com/articles/s43018-0…